Potent and selective of the benzodiazepine site on GABA(A) receptors

Selective antagonist of protease activated receptor-1

Novel CD45 phosphatase inhibitor

Novel small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), exercising broad spectrum anti-inflammatory activity by inhibition of protein binding to the cell surface GAG, heparan sulfate

The first Small Molecule RXFP3/4 Agonist, Increasing Food Intake in Rats Upon Acute Central Administration

Novel potent broad-spectrum antiviral inhibitor, showing excellent broad-spectrum inhibition activity against various pathogenic viruses, including hepatitis c virus (HCV), dengue virus (DENV), zika virus (ZIKV), Chikungunya virus (CHIKV), enterovirus 71

Partial 5-HT1A serotonin receptor agonist

Selective D2 dopamine receptor antagonist; Precursor to radiolabeled S-(-)-raclopride

The most viable GPVI modulator, acting as a potent antithrombotic agent

Novel highly effective tyrosinase inhibitor with great potential to be utilized in anti-Parkinsonian syndrome

Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection

Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection

Inverse agonist of the constitutive androstane receptor (CAR)

FP receptor agonist

Novel HIV-1 integrase inhibitor

Novel inhibitor of D-cyclin transactivation via phosphoinositide 3-kinase pathway

Potent 5-HT1A receptor agonist, also acting as a 5-HT2A and 5-HT2C receptor antagonist

Potent, orally active, partial 5-HT1A receptor agonist

Inhibitor of NADPH oxidase, preventing the structural and functional sequelae of diet-induced metabolic heart disease

Potent and selective thrombin inhibitor for the treatment of thromboembolic disorders

Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors

Selective and highly potent alpha2-adrenoceptor agonist